High-quality generics is an informed doctor's choice in the treatment of glaucoma 22nd Congress of the Russian Glaucoma Society

Abstract

According to the Federal State Statistics Service, about 1.3 million patients with primary glaucoma, one of the leading causes of blindness worldwide, the second-most common after cataract, are registered in Russia. A reasonable solution to the problem of glaucoma, the role and quality of modern generics from the evidence-based standpoint were discussed by participants of the symposium held within the framework of the 22^nd Congress of the Russian Glaucoma Society. The event was moderated by Andrey Brezhnev, Associate Professor of the Department of Ophthalmology, Kursk State Medical University, Head of the Organizational and Methodological Department, Kursk Ophthalmological Clinical Hospital – Regional Publicly Funded Health Facility.